La Costa Group LLC (LCG) is a management consulting firm with senior level expertise in corporate strategy and execution, business development, emerging technology commercialization, operations and finance.
We founded LCG in 1992 to provide high caliber
Curewize Health Ltd
Tech Coast Angels Inc
Investor, Advisor and Business Development Officer
Co-founder and Chief Business Officer and Co-founding Member
Bachelor of Arts ( BA
public policy and economics
III PHD MBA
University of California , Los Angeles
University of California
University of California , Riverside
(23 Total References)
La Costa Group, LLC - Corporate Solutions, Business Development, Strategy
Martin Kleckner, III PHD MBA concentrates on business development, commercialization, capitalization and mentoring of life science start-up ventures including 501(3)c not-for-profit initiatives.His background comprises 26 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
Mr. Kleckner's work comprises a heavy emphasis on business & market development for healthcare companies and hospital systems.
He guides corporations worldwide on the formation of effective business alliances with hospital systems and GPOs.
He specializes in healthcare economics, quality of care, clinical outcomes, operations design & development, sales and market development, cost & productivity and business alliance management initiatives.
Experience includes six-sigma process facilitation; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, and operations management models.
He is currently serving as Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc.
, specializing in the translation of new molecular biology (genomics and proteomics) diagnostics and treatments.
Martin Kleckner, institute co-founder, business adviser and principal of La Costa Group LLC, a Carlsbad firm that consults with clients on developing medical technology ventures, described the approach as one that encompasses the deployment of a blend of charitable funds and grants with venture and corporate development capital that industry partners already have.Kleckner, who has 15 years of experience working for medical device and life sciences companies, said TNCI's partners benefit by receiving licensing fees from the commercialization of intellectual property.
The institute is now engaged in a 30-month campaign using this model to raise the $15 million during a three-phase development process.
Kleckner said the organization hopes to get the ball rolling by a major donor campaign, writing successful grants and seeking the assistance of foundations.
LCG's founder, Martin Kleckner has twenty-four years experience in strategic planning, business development, corporate solutions/strategic accounts, and operations.He has worked on behalf of over 75 emerging businesses and Fortune 100 corporations, with new technology commercialization initiatives, general management and operations, strategic planning and market development.
FLEX PARTNERS, INC. - Bio's - Martin Kleckner, III - Director, Business Development
Martin Klecknersolutions ... ideasBio's - Martin Kleckner, III - Director, Business Development Mr. Kleckner has twenty four (24) years experience in strategic planning, business development, operations and financial management.His background comprises heavy experience in development and management of internal operations, corporate strategies, and conditions impacting company performances.Mr. Kleckner is the founder of La Costa Group, LLC www.lacostagroup.com, a multi-partner consultancy based in Carlsbad, California where he has assisted over 65 companies, both emerging businesses and Fortune 100 corporations with new technology commercialization, capitalization, general management, strategic planning and business development.He has taught programs in sales & marketing, finance, and business economics throughout Europe, Asia and the Americas for several companies including General Electric, Honeywell, Allied Signal, Roche Diagnostics, Toshiba America Medical, AGFA, Fuji Medical, and Hewlett Packard.Before founding La Costa Group, he was Director of Venture Development & Contract Executive at American Healthcare Systems where he was responsible for medical device market growth alliances.At Times Mirror Cable Systems, he served senior positions in finance and marketing and was General Manager for a $17 million division where he had full profit and loss accountability with 155 employees, leading it as the highest financially performing division in 1985 & 1986.He is a former legislative advocate representing businesses in the California state legislature & Washington D.C.Mr. Kleckner earned his MBA from the University of California, Los Angeles (UCLA), an MA in Public Policy from the University of California, Riverside, and holds a BA from Whittier College.He has completed all Ph.D. requirements except dissertation from the University of California and received a certificate in healthcare executive management from the University of California, San Diego.He is a frequent lecturer at national conferences and regularly contributes articles to medical industry journals.
The Art and Science of Investing in a PACS | May 2002 | ImagingEconomics.com
Martin Kleckner IIIOnce upon a time, not too long ago (the 1990s), investment capital seemed easy pickings.It appeared as though everybody (read, "everybody else!") could throw together a business plan and get funded.All the old economics rules went by the wayside.
Thank You for Downloading!
1. Download ZoomInfo Grow
2. Run Installation Wizard
3. Check your inbox to Sign in to ZoomInfo Grow